Brief: Merck KGaA, Darmstadt, Germany, Collaborates With Versant Ventures To Launch Saturnus Bio
Tue 14:36
BRIEF-Merck KGaA, Darmstadt, Germany, Collaborates With Versant Ventures To Launch Saturnus Bio June 23 (Reuters) - Merck KGaA MRCG.DE:
MERCK KGAA, DARMSTADT, GERMANY, COLLABORATES WITH VERSANT VENTURES TO LAUNCH SATURNUS BIO TO ADVANCE TREATMENTS FOR RARE GENETIC CARDIOMYOPATHIES
MERCK KGAA: RESEARCH-STAGE PARTNERSHIP INCLUDES UPFRONT PAYMENT OF $50 MILLION FROM CO, DARMSTADT, GERMANY TO FUND SATURNUS' RESEARCH ACTIVITIES
Source text: ID:nBw6G7KQha
Further company coverage: MRCG.DE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Merck KGaA
See all newsBrief: Merck Collaborates With Versant Ventures To Launch Saturnus Bio
Brief: Merck KGaA, Darmstadt, Germany, Collaborates With Versant Ventures To Launch Saturnus Bio
Brief: Pharma Mar's Partner Merck Submits Application For Lung Cancer Drug Zepzelca In Japan
Europe Research Roundup: ASML Holding, Douglas, Richemont
European shares lifted by miners and tech; Mideast in focus (updated)